Who founded Antheia, Inc.?

Antheia, Inc. was founded by Christina D. Smolke, Christina Smolke, Kristy Hawkins in 2013.

Who are Antheia, Inc.'s investors?

Antheia, Inc.'s investors include America's Frontier Fund, Civilization Ventures Management, Llc, Global Health Investment Corporation, Lam Capital, Sherpalo Ventures.

How much funding has Antheia, Inc. raised?

Antheia, Inc. has disclosed $97.4M raised across 5 rounds.

Where is Antheia, Inc. headquartered?

Antheia, Inc. is headquartered in Menlo Park, US.

Antheia, Inc.

Menlo Park, US · Founded 2013 · Delaware corporation · 67 employees on LinkedIn · 7 known investors

Find your way into Antheia, Inc.

569 people in our graph share verified history with the Antheia, Inc. team — schools, employers, funds. One of them is your warm intro.

Noubar Afeyanunlockedknows Eric d'Esparbes · together at Joule Unlimited, Inc. (overlapped)

knows the team · via Accretive Solutions

knows the team · via Progenity, Inc.

×2knows the team · via Antheia, Inc.

knows the team · via Cell Genesys

knows the team · via Fibrogen

Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.

Advanced Manufacturing Biotech Healthtech

Founders & leadership

Antheia, Inc. was founded in 2013 by Christina D. Smolke, Christina Smolke, and Kristy Hawkins.

Christina D. SmolkeCEO & Co-Founder

Christina SmolkeCo-Founder & CEO

Kristy Hawkins Co-Founder & CSOKristy Hawkins is a co-founder and Chief Science Officer of Antheia, bringing over 15 years of experience in synthetic biology and yeast metabolic engineering for small molecule production. Her expertise spans tool development, high-throughput screening, and pathway engineering applied to fermentation-based pharmaceutical manufacturing.

Eric d'Esparbes Chief Financial OfficerEric d'Esparbes is Chief Financial Officer of Antheia, a biomanufacturing company producing pharmaceutical ingredients through fermentation. He brings extensive experience in financial leadership at public and private biopharmaceutical companies, including interim CEO roles, with demonstrated expertise in capital raising, P&L management across billions in revenue, and regulatory compliance in pharmaceutical and diagnostics sectors.

Zack McGahey Chief Operating OfficerZack McGahey holds a BS in Bioengineering from UC Berkeley and an MBA from Wharton. He has over 20 years of experience in manufacturing and operations, with prior roles including Director of Manufacturing Facilities at Tesla, Vice President of Manufacturing at Zymergen, and Head of Manufacturing at Grifols Diagnostic Solutions, and is currently Chief Operating Officer of Antheia.

Heidi Pucel Chief People OfficerHeidi Pucel is Chief People Officer at Antheia. She has worked across human resources functions including training, employee relations, mergers and acquisitions, recruiting, compensation and benefits, and strategic planning.

Board

Ram ShriramBoard directorManaging Partner at Sherpalo Ventures

Catherine ThodeyBoard director

Investors · 7

America's Frontier Fundlisted by America's Frontier FundArlington · $500K – $10M

How we know: prnewswire.com · Not right? Tell us

Civilization Ventures Management, Llclisted by Civilization Ventures Management, LlcTiburon · $1M – $10M

How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · Not right? Tell us

Global Health Investment Corporationlisted by Global Health Investment CorporationNew York

How we know: Global Health Investment Corporation's portfolio page · fiercepharma.com · Not right? Tell us

Lam Capitallisted by Lam Capital

How we know: Lam Capital's portfolio page · Not right? Tell us

Sherpalo Ventureslisted by Sherpalo VenturesMenlo Park

How we know: Sherpalo Ventures's portfolio page · Not right? Tell us

Also in the syndicate · 2

ATHOS KGleadEDBI

Funding

SEC filings, press & company announcements

$97.4M disclosed across 5 rounds · 2015–2026

$24MSeries CJan 2026 · 3 sources
America's Frontier Fund (lead), ATHOS KG (lead), EDBI, Global Health Investment Corporation
Source ↗
$56MSeries CJun 2025 · 2 sources
Source ↗

▶$9.2MraisedSep 2018 · 5 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Ram ShriramDirector
Valerie MinassianExecutive Officer
Catherine ThodeyDirector
Christina D. SmolkeExecutive Officer, Director

Offering amount: $15.5M
Amount sold: $9.2M
First sale: Aug 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.2MraisedMay 2017 · 4 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Catherine ThodeyDirector
Christina D. SmolkeExecutive Officer, Director
Ram ShriramDirector

Offering amount: $25M
Amount sold: $6.2M
First sale: May 2017
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedMar 2015 · 10 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Ram ShriramDirector
Catherine ThodeyDirector
Christina D. SmolkeExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $2M
First sale: Mar 2015
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Antheia, Inc. went on to found or lead other companies.

Jean SiniInvestorFounded Irregular Expressions Aaron CravensConsultantFounded Revel Pharmaceuticals Patrick Y. YangBoard DirectorFounded Acepodia

In the news

Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy - Antheiaantheia.bio · Jun 2025

Frequently asked questions

What does Antheia, Inc. do?: Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.
Who founded Antheia, Inc.?: Antheia, Inc. was founded by Christina D. Smolke, Christina Smolke, Kristy Hawkins in 2013.
Who are Antheia, Inc.'s investors?: Antheia, Inc.'s investors include America's Frontier Fund, Civilization Ventures Management, Llc, Global Health Investment Corporation, Lam Capital, Sherpalo Ventures.
How much funding has Antheia, Inc. raised?: Antheia, Inc. has disclosed $97.4M raised across 5 rounds.
Where is Antheia, Inc. headquartered?: Antheia, Inc. is headquartered in Menlo Park, US.